Registration for the new eligible population groups (all those above 18 years) will start on Wednesday from 4 pm. Vaccination against COVID-19 began in the country on January 16.
Once available, Sputnik V will be the third vaccine to be used in India against coronavirus. The other two vaccines are Covaxin and Covishield.
Deputy Chief of the Russian Mission (Russian Embassy) Roman Babushkin said that Sputnik vaccine against COVID-19 would definitely support efforts of vaccination in India.
The Drugs Control General of India has permitted emergency use of Covid vaccine Sputnik V with certain conditions, clearing the way for a third vaccine in addition to Covishield and Covaxin.
Two Covid-19 vaccines -- Covaxin and Covishield are being used for inoculation in India. India has just granted permission for emergency use of Russia's Sputnik V vaccine.
The Drug Controller General of India (DCGI) has registered the vaccine under the emergency use authorisation procedure.
Sputnik V is a two dose Covid-19 vaccine. The drug has shown 91.6 per cent efficacy in the phase 3 trial without any major serious side effects.
Sputnik V Vaccine Approved in India: DGCI has approved Russia's Sputnik V vaccine for emergency use in India. Sputnik V becomes the third vaccine that will be administered to Indians.
An expert committee of the government has approved the Russian Covid-19 vaccine Sputnik V for emergency use in India.
Sputnik V is a two dose vaccine. If approved, Sputnik V will be third vaccine in India against coronavirus.
The vaccine manufacturers in India, Dr Reddy's, have already submitted the safety and immunogenicity data of the third phase trials.
At first there were doubts that the efficacy in people aged 60 and over would be lower ... but it was absolutely not," Gintsburg told the SolovyovLive show on YouTube.
The Central Drugs Standard Control Organisation's (CDSCO) Subject Expert Committee (SEC) is going to meet on Wednesday afternoon to discuss Dr Reddy's Laboratories application seeking emergency use approval (EUA) for SputnikV, a Russian Vaccine.
As part of the review process, the drug major will present the safety profile of phase 2 study, and interim data of phase 3 trial, which is expected to be complete by February 21, 2021, Dr Reddy's said in a statement.
Russian scientists say the country's Sputnik V vaccine appears safe and effective against COVID-19, according to early results of an advanced study published on Tuesday in a British medical journal.
The ongoing trial was expected to be completed by February after which it would approach the Drug Controller General of India (DCGI) for EUA and based on its approval the vaccine could be launched in March, DRL's Chief Executive Officer of APIs and Pharmaceutical Services Deepak Sapra said.
Pakistan has authorised the emergency use of Russia’s Sputnik V, the third anti-COVID-19 vaccine approved by the country against the deadly coronavirus, authorities said on Sunday.
The Brazil National Health Surveillance Agency (Anvisa) declined the request to approve the Russian-developed Sputnik V vaccine against COVID-19 for emergency use in Brazil.
Almost a year into the COVID-19 pandemic, about 200 vaccine candidates are in the works and 10 have been either approved by several countries or are under limited emergency use.
Belarus becomes the first country in the world after Russia to start vaccination of its people against COVID-19 with Sputnik V vaccine: Russian Direct Investment Fund (RDIF)
Top News
Latest News
